Other Viruses Citation List: January 2 - January 15, 2015
Hepatitis B Virus
1. Discovering Novel Direct Acting Antiviral Agents for HBV Using in Silico Screening. Murakami, Y., M. Hayakawa, Y. Yano, T. Tanahashi, M. Enomoto, A. Tamori, N. Kawada, M. Iwadate, and H. Umeyama. Biochemical and Biophysical Research Communications, 2015. 456(1): p. 20-28. PMID[25446116].
[PubMed]. OV_0102-011515.
Hepatitis C Virus
2. Boronic acid-modified Lipid Nanocapsules: A Novel Platform for the Highly Efficient Inhibition of Hepatitis C Viral Entry. Khanal, M., A. Barras, T. Vausselin, L. Feneant, R. Boukherroub, A. Siriwardena, J. Dubuisson, and S. Szunerits. Nanoscale, 2015. 7(4): p. 1392-1402. PMID[25502878].
[PubMed]. OV_0102-011515.
3. Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host Cells. Ruiz-Sanchis, P., B.M. Wohl, A.A. Smith, K. Zuwala, J. Melchjorsen, M. Tolstrup, and A.N. Zelikin. Advanced Healthcare Materials, 2015. 4(1): p. 65-68. PMID[25132665].
[PubMed]. OV_0102-011515.
Human Cytomegalovirus
4. Glucocorticosteroids Trigger Reactivation of Human Cytomegalovirus from Latently Infected Myeloid Cells and Increase the Risk for HCMV Infection in D+R+ Liver Transplant Patients. Van Damme, E., S. Sauviller, B. Lau, B. Kesteleyn, P. Griffiths, A. Burroughs, V. Emery, J. Sinclair, and M. Van Loock. The Journal of General Virology, 2015. 96(Pt 1): p. 131-143. PMID[25312585].
[PubMed]. OV_0102-011515.
Citations from the ISI Web of Knowledge Listings for O.V.
5. Biological and Structural Characterization of Rotamers of C-C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096. Kazmierski, W.M., S. Danehower, M.S. Duan, R.G. Ferris, V. Elitzin, D. Minick, M. Sharp, E. Stewart, and M. Villeneuve. ACS Medicinal Chemistry Letters, 2014. 5(12): p. 1296-1299. ISI[000346322500007].
[WOS]. OV_0102-011515.